EU Approves Medicine to Prevent Children's Bronx

The European Commission has just approved a new treatment for preventing a common and highly contagious virus that causes in babies the tank. The AstraZeneca component of Great Britain and the Sanofi of France said on Friday their newly approved drug önisevimabi is the first treatment to prevent serious diseases caused [...]
The AstraZeneca Compatia of Great Britain and France's Sanofi said on Friday their newly approved drug énisevimab; it is the first treatment to prevent serious diseases caused by the virus “cial” of breathing (RSV) in babies.
This type of virus infects almost all children by the age of two, companies said, Euronews.
The most common cause of bronkiolit is a respiratory infection that can seriously ill babies and cause them to lie in hospital.
In the United States, the product is still under consideration as a possible progressive therapy.
Technically, it's not a vaccine, it's an antibodies treatment that increases immunity in babies.












